Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI).
1.What is colchicine and why study it in PCI?
2.What was the study design, patient population and primary and secondary outcomes?
3.What were your outcomes?
4.How do these compare to those in the COLCOT study?
5.How should your study be interpreted in clinical practice and influence further research in this field?
Filmed on site at AHA 2019 by Radcliffe Cardiology.
Interviewer: Liam O'Neill
Videographer: Tom Green & Dominic Woodruff